Fed. Circ. Makes It Binding: Arthrex Redo Is For Patent Owner
The Federal Circuit on Tuesday reissued as precedent its ruling that patent challengers can't leverage Arthrex to get a new hearing at the Patent Trial and Appeal Board, following the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article